NHS patients across the North East and North Cumbria are set to benefit from a major capital investment to expand pharmaceutical services across the region’s entire hospital network.

Thanks to a joint bid submitted through the region’s Provider Collaborative*, £29.7 million of national NHS funding has been secured. It will be used to create a new state-of-the-art sterile drug manufacturing hub to serve all eight hospital and community NHS Foundation Trusts in the region.

свернуть